Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) announced its earnings results on Wednesday. The company reported $0.18 earnings per share for the quarter, Zacks reports. The business had revenue of $6.01 billion during the quarter.
Fresenius SE & Co. KGaA Price Performance
Shares of Fresenius SE & Co. KGaA stock opened at $9.97 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.36 and a debt-to-equity ratio of 0.57. The business has a fifty day simple moving average of $9.35 and a 200 day simple moving average of $9.20. Fresenius SE & Co. KGaA has a 12 month low of $6.57 and a 12 month high of $10.42.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More
- Five stocks we like better than Fresenius SE & Co. KGaA
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Why Smart Investors Are Watching These 3 Undervalued Stocks
- What Investors Need to Know to Beat the Market
- 3 Stocks Breaking Out with More Growth Potential Ahead
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
